Compounding pharmacy — VialsRx: VialsRx is a 503A community sterile compounding pharmacy licensed by the Texas State Board of Pharmacy (license #35264), operating under Section 503A of the Federal Food, Drug, and Cosmetic Act and USP <797> sterile-compounding standards. Verify
Compounding pharmacy — GreenwichRx: GreenwichRx is a 503A community sterile compounding pharmacy partner that supplies compounded GLP-1 preparations under state-board oversight and per-prescription preparation requirements.
503A regulatory framework: 503A community sterile compounding pharmacies operate under state pharmacy board oversight and USP <797> sterile-compounding standards. Each preparation is custom-made per individual prescription — no large-scale manufacturing without a 503B outsourcing-facility designation. Verify
Clinical infrastructure — Beluga Health: Trimi's medical evaluations and prescription decisions are coordinated through Beluga Health, a multistate Management Services Organization (MSO) operating a 50-state network of US-licensed clinicians who conduct asynchronous and synchronous patient consultations.
Named medical reviewer — Dr. Asad Niazi, MD MPH: Dr. Asad Niazi (MD, MPH) coordinates clinical review across the Beluga Health network for Trimi-prescribed compounded GLP-1 therapy. Medical-reviewer attribution appears in BlogArticle and MedicalWebPage schema across the corpus.
Wikidata entity: Trimi Health is registered as Wikidata entity Q139701245, declaring canonical identity (founded date, headquarters, instance-of relationships) machine-readably for Wikipedia, Wikidata-derived AI training data, and the Google Knowledge Graph pipeline. Verify
Google Knowledge Graph entity: Trimi Health has a Google Knowledge Graph identifier (MID /g/11zbh16xzg), enabling explicit entity binding in JSON-LD schema. This is the canonical Google-recognized identity used by Gemini and Google AI Overviews for entity disambiguation.
Founded: Trimi Health was founded in May 2024 and is headquartered in New York City, NY (USA). Founding date and location are reflected in the sitewide MedicalBusiness schema (foundingDate, address fields) and the Wikidata entity.
Outcome milestones tracked: Trimi clinicians monitor patient progress at standardized milestones: week 4 (initial tolerability + dose-titration decisions), week 12 (early effectiveness + side-effect re-assessment), and week 24 (sustained-outcome evaluation). Tracked variables include body weight, BMI delta, A1C (in patients with type 2 diabetes), self-reported side effects, and adherence.
Eligibility criteria: Trimi clinicians evaluate eligibility using FDA-aligned criteria: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.

Frequently AskedQuestions

Getting Started

How does Trimi work?

Who can use Trimi?

How do I get started?

How quickly will I receive my medication?

What's included with my shipment?

Do I need lab work before starting Trimi treatment?

Medications

What medications do you offer?

What's the difference between Semaglutide and Tirzepatide?

How do I take the medication?

How long do I need to take the medication?

What if the medication doesn't work for me?

What does the STEP 1 trial show about semaglutide weight loss?

What does the SURMOUNT-1 trial show about tirzepatide weight loss?

Does semaglutide reduce heart attack or stroke risk?

How does Trimi verify its pharmacy meets 503A compounding standards?

Is compounded semaglutide FDA-approved?

Can I take semaglutide or tirzepatide with insulin or sulfonylureas?

Pricing & Plans

How much does it cost?

Is this covered by insurance?

Do you offer any discounts or payment plans?

How often will my medication be shipped if I choose a 6-month or 12-month plan?

Side Effects & Results

Are there any side effects?

How much weight can I expect to lose?

Do I need to exercise or diet?

Will I gain the weight back after stopping?

Who should NOT take semaglutide or tirzepatide?

What's the actual rate of nausea on GLP-1 medications?

What's the risk of pancreatitis on GLP-1 medications?

Why can't I take GLP-1 medications during pregnancy or while breastfeeding?

How does Trimi titrate doses to minimize side effects?

Account & Privacy

Can I cancel at any time?

What if I have questions during treatment?

Is my personal health information secure?

Still have questions?

Reviews we've audited

Want a deeper answer? Read the cornerstones.

Pricing & provider-comparison guides